- Zug, Switzerland
- Hybrid · 2 days in office
- US$242,250 – US$403,750 pa
- Director · manages people
Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.